Nuvation Bio Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -41.66M-86.85M-104.20M-75.80M-567.94M
Share-based Compensation 2.20M9.27M16.29M19.51M32.27M
Gains from Investment Securities -4.23M-10.19M1.22M6.03M
Non-cash Items 9.37M24.25M
Change in Interest Receivables 0.26M1.95M-0.55M1.22M-0.13M
Cash from Operations -36.53M-68.19M-96.11M-68.00M-130.41M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -4.59M-3.67M12.06M9.00M
Depreciation & Amortization (CF) 0.10M0.20M0.20M0.22M0.70M
Change in Working Capital
Change in Receivables 12.72M
Change in Account Payables 0.03M1.86M-1.79M0.07M-1.65M
Change in Accured Expenses 2.92M7.45M-2.32M-0.02M6.84M
Investing Activities
Capital Expenditures 0.14M0.28M0.37M0.07M0.16M
Sales of Property, Plant and Equipment 0.01M0.01M
Acquisitions 19.86M
Change in Acquisitions & Divestments 70.61M154.91M584.12M712.35M450.08M
Cash from Investing Activities -70.32M-454.67M63.46M8.92M122.70M
Financing Activities
Other financing activities 0.28M-0.00M17.16M
Debt Issuance and Repayment
Long-Term Debt Issuances 135.66M
Short-Term Debt issuances 12.61M
Change in Capital Stock
Shares Issued 135.66M-3.79M0.94M0.38M4.46M
Misc.
Cash from Financing Activities 133.13M625.53M1.33M0.63M0.33M
Exchange Rate Effect 0.45M
Change in Cash 26.29M102.67M-31.32M-58.45M-6.93M
Beginning Cash Balance -26.29M-102.67M31.32M101.10M42.65M
Free Cash Flow -36.67M-68.47M-96.48M-68.07M-130.57M
Net Cash Flow 26.29M102.67M-31.32M-58.45M-7.38M